Coherus Oncology Inc (CHRS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2013 | 06-2013 | 12-2012 | 09-2012 | 03-2012 | |
| Sales | 506 | 506 | 0 | 0 | 481,263 |
| Cost of Goods | N/A | 0 | N/A | 0 | 219,529 |
| Gross Profit | 506 | 506 | N/A | 0 | 261,734 |
| Operating Expenses | 7,289 | 2,355 | 0 | 0 | 234,358 |
| Operating Income | -6,783 | -1,849 | N/A | 0 | 27,376 |
| Interest Expense | 1,992 | 1,992 | 0 | 0 | 3,140 |
| Other Income | -12,698 | -17,632 | 0 | 0 | 348 |
| Pre-tax Income | -21,473 | -21,473 | 0 | 0 | 24,584 |
| Income Tax | N/A | 0 | N/A | 0 | 6,812 |
| Net Income Continuous | -21,473 | -21,473 | N/A | 0 | 17,772 |
| Net Income | $-21,473 | $-21,473 | $N/A | $0 | $17,772 |
| EPS Basic Total Ops | -6.23 | N/A | N/A | N/A | N/A |
| EPS Basic Continuous Ops | -6.23 | N/A | N/A | N/A | N/A |
| EPS Diluted Total Ops | -6.23 | N/A | N/A | N/A | N/A |
| EPS Diluted Continuous Ops | -6.23 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-6,783 | $-1,849 | $N/A | $0 | $27,376 |